Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Cell Adhesion Molecule 3 (CADM3) (Middle Region) Peptid

CADM3 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN974396

Kurzübersicht für Cell Adhesion Molecule 3 (CADM3) (Middle Region) Peptid (ABIN974396)

Target

CADM3 (Cell Adhesion Molecule 3 (CADM3))

Spezies

Human

Quelle

  • 4
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequenz

    KDTATLNCQS SGSKPAARLT WRKGDQELHG EPTRIQEDPN GKTFTVSSSV

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-CADM3 Antibody(ARP49641_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    CADM3 (Cell Adhesion Molecule 3 (CADM3))

    Hintergrund

    IGSF4B is a brain-specific protein related to the calcium-independent cell-cell adhesion molecules known as nectins (see PVRL3, MIM 607147) (Kakunaga et al., 2005 [PubMed 15741237]).

    Alias Symbols: BIgR, FLJ10698, IGSF4B, NECL1, Necl-1, TSLL1, synCAM3

    Protein Size: 432

    Molekulargewicht

    47 kDa

    Gen-ID

    57863

    NCBI Accession

    NM_021189, NP_067012

    UniProt

    Q8N126
Sie sind hier:
Chat with us!